Document is current

Any future updates will be listed below

Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer

Crossref DOI link: https://doi.org/10.1245/s10434-015-4754-2

Published Online: 2015-07-29

Published Print: 2015-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark